glp-1 shortage us Use of diabetes and anti-obesity drugs surges nationwide GLP-1 No Longer on FDA's

GLP-1 receptor agonists work by: Stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps regulate blood sugar levels Slowing gastric emptying , meaning food remains in the stomach longer, promoting feelings of fullness Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger signals and food cravings Decreasing glucagon secretion , which helps prevent excessive glucose production by the liver Most GLP-1 agonists are administered via subcutaneous injection, typically once weekly or once daily depending on the specific formulation, though oral semaglutide (Rybelsus) is also available

You may find yourself reaching for a mid-morning snack out of habit, only to realize you arent actually hungry

Ueno Y, Kizaki M, Nakagiri R, Kamiya T, Sumi H, Osawa T

Introduction You wake up, but your brain feels like it is still stuck in the fog of yesterday